Rockwell Medical (NASDAQ:RMTI) Receives Buy Rating from HC Wainwright

HC Wainwright restated their buy rating on shares of Rockwell Medical (NASDAQ:RMTI – Free Report) in a report issued on Wednesday morning, Benzinga reports. They currently have a $11.00 target price on the stock. Several other equities analysts also recently commented on the stock. Maxim Group assumed coverage on shares of Rockwell Medical in a […]

Leave a Reply

Your email address will not be published.

Previous post AECOM (NYSE:ACM) Upgraded by StockNews.com to “Buy”
Next post Titan Pharmaceuticals (NASDAQ:TTNP) Receives New Coverage from Analysts at StockNews.com